Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAllergy Thera. Share News (AGY)

Share Price Information for Allergy Thera. (AGY)

Share Price is delayed by 15 minutes
Get Live Data
7.50    -0.40 (-5.06%)
Bid:
7.00
Ask:
8.00
Spread: 1.00 (14.286%)
Market Cap: £474.94m
AGY Live PriceLast checked at - London Stock Exchange

Intraday Allergy Thera. Share Chart

Allergy Thera. News

Allergy Therapeutics forecasts revenue drop but trials going well
14 Feb 2024

Allergy Therapeutics forecasts revenue drop but trials going well

(Alliance News) - Allergy Therapeutics PLC on Wednesday said revenue decreased in its latest half year, and expects to require further funding soon.

TRADING UPDATES: Alliance Pharma appoints chair; FireAngel sales down
5 Feb 2024

TRADING UPDATES: Alliance Pharma appoints chair; FireAngel sales down

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported...

Allergy Therapeutics resumes trading on AIM; annual revenue plunges
30 Jan 2024

Allergy Therapeutics resumes trading on AIM; annual revenue plunges

(Alliance News) - Allergy Therapeutics PLC on Tuesday resumed trading on AIM after the release of its annual results.

IN BRIEF: Allergy Therapeutics amends facility, plans warrant issue
27 Dec 2023

IN BRIEF: Allergy Therapeutics amends facility, plans warrant issue

Allergy Therapeutics PLC - Sussex-based biotechnology company specialising in allergy vaccines - Shares rise as firm enters amendment to the facility ...

EARNINGS AND TRADING: Redx full year revenue tumbles; loss widens
15 Dec 2023

EARNINGS AND TRADING: Redx full year revenue tumbles; loss widens

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported...

Allergy Therapeutics shares jump as hails grass allergy jab data
13 Dec 2023

Allergy Therapeutics shares jump as hails grass allergy jab data

(Alliance News) - Allergy Therapeutics PLC on Wednesday said that phase-3 trials of its grass allergy injection yielded positive results, moving the p...

AIM WINNERS & LOSERS: Impellam climbs on GBP483 million takeover offer
13 Dec 2023

AIM WINNERS & LOSERS: Impellam climbs on GBP483 million takeover offer

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.